Konidaris Tasos
Executive Vice President & CFO · 13 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-04 | AMRX | Amneal Pharmaceuticals, Inc. | Tax withholding | 22,035 | $13.30 | $293,065.50 | filing |
| 2026-03-04 | AMRX | Amneal Pharmaceuticals, Inc. | Option exercise | 43,982 | — | — | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Tax withholding | 229,817 | $13.31 | $3.1M | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Tax withholding | 24,251 | $13.31 | $322,780.81 | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Tax withholding | 16,182 | $13.31 | $215,382.42 | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Tax withholding | 14,298 | $13.31 | $190,306.38 | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Option exercise | 28,538 | — | — | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Option exercise | 45,290 | — | — | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Option exercise | 57,339 | — | — | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Option exercise | 458,716 | — | — | filing |
| 2025-08-15 | AMRX | Amneal Pharmaceuticals, Inc. | Sale | 219,159 | $9.43 | $2.1M | filing |
| 2025-08-14 | AMRX | Amneal Pharmaceuticals, Inc. | Sale | 119,206 | $9.30 | $1.1M | filing |
| 2025-08-13 | AMRX | Amneal Pharmaceuticals, Inc. | Sale | 161,365 | $9.22 | $1.5M | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.